Kenta Kojima

Learn More
BACKGROUND HER2 testing for samples from recurrent or metastatic disease is recommended by the 2013 update of the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines and cytological analysis can be applied to several types of metastatic lesions. However, the practical method to assess the HER2 testing of breast(More)
Editorial New year's greetings M. Mizuguchi (Japan) 1 Memorial Dr. Masaya Segawa, Japanese pioneer in child neurology K. Hoshino (Japan) 2 Review Articles Contributions of Japanese patients to development of antisense therapy for DMD Original Articles Pediatric epilepsy following neonatal seizures symptomatic of stroke (Italy) 27 Predictive factors for(More)
BACKGROUND Human epidermal growth factor receptor 2 (HER2) testing of samples from recurrent or metastatic breast cancer is recommended by the 2013 update of the American Society of Clinical Oncology/College of American Pathologists guidelines. Although cytological analysis can be applied to several types of metastatic lesions, the practical method for HER2(More)
  • 1